EastWest Bioscience Inc.

EAST.H

CA27783V1076

Other Specialty Retailers

Delayed Toronto S.E. Other stock markets 05:24:31 28/04/2023 BST			5-day change	1st Jan Change
0.025 ^CAD	-.--%		-.--%	-.--%

2022	EastWest Bioscience Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended April 30, 2022	CI
2022	EastWest Bioscience Inc. Reports Earnings Results for the Second Quarter and Six Months Ended January 31, 2022	CI

EastWest Bioscience Inc. completed the acquisition of remaining 50% stake in 1123573 BC Ltd. and Orchard Valley Naturals Ltd. from Darryl Sangster, Aquila Health Corp. and Sangster's Real Estate Corp.

February 10, 2020

EastWest Bioscience Inc. (TSXV:EAST) agreed to acquire remaining 50% stake in 1123573 BC Ltd. and Orchard Valley Naturals Ltd. from Darryl Sangster, Aquila Health Corp. and Sangster's Real Estate Corp. for CAD 0.08 million on December 18, 2019. Under the terms of the agreement, EastWest Bioscience Inc. will pay 2.77 million shares as consideration. EastWest Bioscience Inc. already hold 50% stake in 1123573 BC Ltd. and Orchard Valley Naturals Ltd. Post acquisition, EastWest Bioscience Inc. will hold 100% stake in 1123573 BC Ltd. and Orchard Valley Naturals Ltd. The transaction is subject to approval of the TSX Venture Exchange. EastWest Bioscience Inc. (TSXV:EAST) completed the acquisition of remaining 50% stake in 1123573 BC Ltd. and Orchard Valley Naturals Ltd. from Darryl Sangster, Aquila Health Corp. and Sangster's Real Estate Corp. on February 11, 2020.

Latest news about EastWest Bioscience Inc.

EastWest Bioscience Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended April 30, 2022	29/06/22	CI
EastWest Bioscience Inc. Reports Earnings Results for the Second Quarter and Six Months Ended January 31, 2022	31/03/22	CI
EastWest Bioscience Inc. Reports Earnings Results for the First Quarter Ended October 31, 2021	29/12/21	CI
EastWest Bioscience Inc. Reports Earnings Results for the Full Year Ended July 31, 2021	03/12/21	CI
EastWest Bioscience Inc. Auditor Raises 'Going Concern' Doubt	02/12/21	CI
EastWest Bioscience Inc. Adds Oliver to Its Self-Storage Location Portfolio	24/09/21	CI
EastWest Bioscience Inc. Adds Self-Storage to Penticton Facility	03/09/21	CI
EastWest Bioscience Inc. Announces Earnings Results for the Third Quarter Ended April 30, 2021	28/06/21	CI
EastWest Bioscience Inc. Restructures Workforce by Reducing Number of Staff and Focusing on Automation and Streamlining Existing Processes	01/03/21	CI
Eastwest Bioscience Inc. Reports Earnings Results for the First Quarter Ended October 31, 2020	15/01/21	CI
Eastwest Bioscience Inc. Announces Executive Changes	05/01/21	CI
Eastwest Bioscience Inc. Reports Earnings Results for the Full Year Ended July 31, 2020	29/12/20	CI
EastWest Bioscience Inc. Auditor Raises 'Going Concern' Doubt	28/12/20	CI
EastWest Bioscience Group Announces Executive Changes at Sangsters Health Centre	22/10/20	CI
Eastwest Bioscience Inc. Reports Earnings Results for the Third Quarter Ended April 30, 2020	28/06/20	CI
EastWest Bioscience Inc. announced that it has received CAD 0.099636 million in funding	24/06/20	CI
EastWest Bioscience Inc. announced that it expects to receive CAD 0.1 million in funding	17/06/20	CI
EastWest Bioscience Inc. completed the acquisition of remaining 50% stake in 1123573 BC Ltd. and Orchard Valley Naturals Ltd. from Darryl Sangster, Aquila Health Corp. and Sangster's Real Estate Corp.	10/02/20	CI
Eastwest Bioscience Inc. Reports Earnings Results for the First Quarter Ended October 31, 2019	10/02/20	CI
EastWest Bioscience Inc. Announces the Construction Completed on Eastwest's Kentucky, USA CBD Processing and Bottling Line	06/02/20	CI
Eastwest Bioscience Inc. Reports Earnings Results for the Full Year Ended July 31, 2019	28/01/20	CI
EastWest Bioscience Inc. agreed to acquire remaining 50% stake in 1123573 BC Ltd. and Orchard Valley Naturals Ltd. from Darryl Sangster, Aquila Health Corp. and Sangster's Real Estate Corp. for CAD 0.08 million.	17/12/19	CI
Eastwest Bioscience Group Continues Expansion into the US Market with the Construction on its CBD Processing and Bottling Line Nearing Completion	27/11/19	CI
InnerScope Hearing Technologies Inc. Establishes a Distribution, Warehousing, and Manufacturing Agreement in Canada and the United States with EASTWEST BIOSCIENCE INCBioscience Inc	06/11/19	CI
EastWest Bioscience Inc. Completes First Production Run of CBD Pet Treats for the US Market	30/10/19	CI

Chart EastWest Bioscience Inc.

Duration

Period

More charts

Company Profile

Eastwest Bioscience Inc. is a Canada-based vertically integrated wellness company. The Company has a multitude of business units and assets that allow for seed-to-sale supply chain management. The Company sources its raw materials, processes, manufactures, tests, brands, markets and distributes its products to its customers in Canada, the United States, and other countries. The Company owns and operates retail and manufacturing subsidiaries. Its retail subsidiary is a Canada-based natural health retail franchise, the Sangster's Health Centre's, which is involved in the health and wellness industry. Orchard Vale Naturals is the Company's manufacturing arm that is certified with a Health Canada Site License and has GMP Certified NHP Manufacturing capabilities. Orchard Vale Naturals is specialized in custom blends and production runs of all sizes, small to large. Orchard Vale Naturals operates out of the approximately 34,000 square Health Canada licensed facility in Penticton, British Col

Sector

Other Specialty Retailers

More about the company

Sector Other Miscellaneous Specialty Retailers

	1st Jan change	Capi.
EASTWEST BIOSCIENCE INC.	-.--%	1.85M
TRACTOR SUPPLY COMPANY	+30.78%	30.4B
AVOLTA AG	+7.44%	5.89B
JARIR MARKETING COMPANY	-17.46%	4.17B
JUMBO S.A.	+6.85%	4B
GRUPO GIGANTE, S. A. B. DE C. V.	+4.23%	1.91B
UPBOUND GROUP, INC.	-7.89%	1.69B
WINMARK CORPORATION	-15.33%	1.23B
SALLY BEAUTY HOLDINGS, INC.	-13.25%	1.16B
LESLIE'S, INC.	-21.06%	944M

Other Miscellaneous Specialty Retailers